| Intrinsic Valuation of: CRWD | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2021 | - | - | EPS (FY) | -1 | Market Cap | $151B | |||||
| 2022 | - | - (-) | P/E Ratio | - | Total Asset | $11B | |||||
| 2023 | $675M | - (-) | Net Income | $-163M | Total Debt | $745M | |||||
| 2024 | $929M | 37.7% (1.0%) | EBITDA | $182M | Total Liab | $7B | |||||
| 2025 | $1B | 14.9% (-11.2%) | Opr Margin | -6.10 | Debt/Equity | 0.17 | |||||
| 2026 | $1B | 16.3% (-4.5%) | PreTax Margin | -6.68 | BV/Share | 12 | |||||
| 5Y Average FCF | $978M | 15.0% (-4.9%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 9.28% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2027 | $1B | MBG Intrinsic Value | $-6 | ||||||||
| 2028 | $2B | ||||||||||
| 2029 | $2B | ||||||||||
| 2030 | $2B | ||||||||||
| 2031 | $2B | ||||||||||
| 2032 | $2B | ||||||||||
| Terminal Value | $29B | Net Worth/Share | $18 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $24B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $5B | $113 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $745M | WACC | 7.3% | 135 | 143 | 154 | 166 | 183 | |||
| Equity Value | $29B | 8.3% | 117 | 123 | 130 | 138 | 148 | ||||
| Shares Outstanding | 254,536,521 | 9.3% | 104 | 108 | 113 | 119 | 125 | ||||
| 10.3% | 94 | 97 | 100 | 104 | 109 | ||||||
| DCF Intrinsic Value | $113 | 11.3% | 86 | 88 | 91 | 94 | 97 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||